Skip to main content
RT @HealioRheum: Dr. Jack Cush @RheumNow drills down the differences in seropositive vs. seronegative #rheumatoidarthritis - and the potent…

Healio Rheumatology HealioRheum

6 years 8 months ago
Dr. Jack Cush @RheumNow drills down the differences in seropositive vs. seronegative #rheumatoidarthritis - and the potential for misdiagnosis #RWCS2020 https://t.co/VWYYO6gMpR https://t.co/3KY2fDXqMr
RT @Janetbirdope: Common sense should prevail if ordering and interpreting RF and ACPA. Jack Cush nails common sense with rules. #RWCS2020…

Janet Pope Janetbirdope

6 years 8 months ago
Common sense should prevail if ordering and interpreting RF and ACPA. Jack Cush nails common sense with rules. #RWCS2020 @RheumNow https://t.co/ebdY4VmUSV
RT @Janetbirdope: Does telemedicine really save money OR add to costs? #RWCS2020 @RheumNow https://t.co/673JCW9pkU

Janet Pope Janetbirdope

6 years 8 months ago
Does telemedicine really save money OR add to costs? #RWCS2020 @RheumNow https://t.co/673JCW9pkU
RT @Janetbirdope: Head to head Ixe vs Adalimumab in PsA is superior on skin with Ixe and equal on jts. MTX was allowed and seemed to improv…

Janet Pope Janetbirdope

6 years 8 months ago
Head to head Ixe vs Adalimumab in PsA is superior on skin with Ixe and equal on jts. MTX was allowed and seemed to improve Adalimumab response not true for Ixe. May change Rx landscape in PsA. #RWCS2020 @RheumNow https://t.co/Ms2w87TKL8
RT @uptoTate: Mortality rates based on ab status in SSc. Dr. Pope @RheumNow @RWCSmtg #RWCS2020 https://t.co/Wo34p1R4cl

Dr. Rachel Tate uptoTate

6 years 8 months ago
Mortality rates based on ab status in SSc. Dr. Pope @RheumNow @RWCSmtg #RWCS2020 https://t.co/Wo34p1R4cl
RT @uptoTate: Remember that one spot of PsO that won’t go away on your well controlled PsO patient? It may be due to resident T cells loca…

Dr. Rachel Tate uptoTate

6 years 8 months ago
Remember that one spot of PsO that won’t go away on your well controlled PsO patient? It may be due to resident T cells locally. Now what can we do about it? Drs. Ruderman and Kavanaugh @RheumNow @RWCSmtg #RWCS2020 https://t.co/1nrtgxOGYW
RT @Janetbirdope: Telemedicine in rheumatology. Likely not appropriate for all visits with inflammatory arthritis. Aren’t we the last hold…

Janet Pope Janetbirdope

6 years 8 months ago
Telemedicine in rheumatology. Likely not appropriate for all visits with inflammatory arthritis. Aren’t we the last hold outs of doing a physical exam? #RWCS2020 @RheumNow https://t.co/2U9QO5jl3o
RT @uptoTate: Check out CORRONA data regarding the use of Otezla and bDMARDs. We tend to use it in women, pts w/ higher BMI, depression, an…

Dr. Rachel Tate uptoTate

6 years 8 months ago
Check out CORRONA data regarding the use of Otezla and bDMARDs. We tend to use it in women, pts w/ higher BMI, depression, and those with prior bDMARD failure. @RheumNow @RWCSmtg #RWCS2020 https://t.co/t63TTCLTk6
RT @Janetbirdope: Best advice if taking pics of slides. Get Microsoft office lens free ap. Ends your trapezoid pics. #RWCS2020 @RheumNow ht…

Janet Pope Janetbirdope

6 years 8 months ago
Best advice if taking pics of slides. Get Microsoft office lens free ap. Ends your trapezoid pics. #RWCS2020 @RheumNow https://t.co/9LqwxEImLM
RT @Janetbirdope: Cool way to visualize Rx options in PsA. Data from A Kavanaugh #RWCS2020 @RheumNow https://t.co/XobnUbVhiA

Janet Pope Janetbirdope

6 years 8 months ago
Cool way to visualize Rx options in PsA. Data from A Kavanaugh #RWCS2020 @RheumNow https://t.co/XobnUbVhiA
RT @Janetbirdope: Guidelines from GRAPPA are more inclusive than ACR. ACR lacks most MOA drugs other than TNFis #RWCS2020 @RheumNow https:/…

Janet Pope Janetbirdope

6 years 8 months ago
Guidelines from GRAPPA are more inclusive than ACR. ACR lacks most MOA drugs other than TNFis #RWCS2020 @RheumNow https://t.co/7k4HCllzfE
RT @uptoTate: EXCEED SECU vs ADA results in treatment naive pts. #RWCS2020 @RheumNow @RWCSmtg https://t.co/VF7Y7p4H2H

Dr. Rachel Tate uptoTate

6 years 8 months ago
EXCEED SECU vs ADA results in treatment naive pts. #RWCS2020 @RheumNow @RWCSmtg https://t.co/VF7Y7p4H2H
RT @Janetbirdope: REMS is nothing to sleep about Not REM sleep but FDA may impose risk mitigation strategies post marketing. It applies to…

Janet Pope Janetbirdope

6 years 8 months ago
REMS is nothing to sleep about Not REM sleep but FDA may impose risk mitigation strategies post marketing. It applies to some drugs such as Coxibs and Actemra vs Etanercept ENTRACT RCT for CV safety and Belimumab in SLE for safety. All equally safe #RWCS2020 @RheumNow https://t.co/b3rDlcABwL
RT @uptoTate: A review of the 2015 GRAPPA guidelines from Drs. Kavanaugh and Ruderman #RWCS2020 @RheumNow @RWCSmtg https://t.co/45P3VzR4hj

Dr. Rachel Tate uptoTate

6 years 8 months ago
A review of the 2015 GRAPPA guidelines from Drs. Kavanaugh and Ruderman #RWCS2020 @RheumNow @RWCSmtg https://t.co/45P3VzR4hj
×